220 related articles for article (PubMed ID: 21764859)
1. Combination of atorvastatin with sulindac or naproxen profoundly inhibits colonic adenocarcinomas by suppressing the p65/β-catenin/cyclin D1 signaling pathway in rats.
Suh N; Reddy BS; DeCastro A; Paul S; Lee HJ; Smolarek AK; So JY; Simi B; Wang CX; Janakiram NB; Steele V; Rao CV
Cancer Prev Res (Phila); 2011 Nov; 4(11):1895-902. PubMed ID: 21764859
[TBL] [Abstract][Full Text] [Related]
2. Chemoprevention of colon carcinogenesis by sulindac, a nonsteroidal anti-inflammatory agent.
Rao CV; Rivenson A; Simi B; Zang E; Kelloff G; Steele V; Reddy BS
Cancer Res; 1995 Apr; 55(7):1464-72. PubMed ID: 7882354
[TBL] [Abstract][Full Text] [Related]
3. Nitric oxide-releasing aspirin and indomethacin are potent inhibitors against colon cancer in azoxymethane-treated rats: effects on molecular targets.
Rao CV; Reddy BS; Steele VE; Wang CX; Liu X; Ouyang N; Patlolla JM; Simi B; Kopelovich L; Rigas B
Mol Cancer Ther; 2006 Jun; 5(6):1530-8. PubMed ID: 16818512
[TBL] [Abstract][Full Text] [Related]
4. Chemopreventive efficacy of raloxifene, bexarotene, and their combination on the progression of chemically induced colon adenomas to adenocarcinomas in rats.
Janakiram NB; Mohammed A; Zhang Y; Brewer M; Bryant T; Lightfoot S; Steele VE; Rao CV
Cancer Prev Res (Phila); 2013 Dec; 6(12):1251-61. PubMed ID: 24080207
[TBL] [Abstract][Full Text] [Related]
5. Prevention of azoxymethane-induced colon cancer by combination of low doses of atorvastatin, aspirin, and celecoxib in F 344 rats.
Reddy BS; Wang CX; Kong AN; Khor TO; Zheng X; Steele VE; Kopelovich L; Rao CV
Cancer Res; 2006 Apr; 66(8):4542-6. PubMed ID: 16618783
[TBL] [Abstract][Full Text] [Related]
6. Chemopreventive effect of S-methylmethane thiosulfonate and sulindac administered together during the promotion/progression stages of colon carcinogenesis.
Reddy BS; Kawamori T; Lubet R; Steele V; Kelloff G; Rao CV
Carcinogenesis; 1999 Aug; 20(8):1645-8. PubMed ID: 10426822
[TBL] [Abstract][Full Text] [Related]
7. Dietary intake of pterostilbene, a constituent of blueberries, inhibits the beta-catenin/p65 downstream signaling pathway and colon carcinogenesis in rats.
Paul S; DeCastro AJ; Lee HJ; Smolarek AK; So JY; Simi B; Wang CX; Zhou R; Rimando AM; Suh N
Carcinogenesis; 2010 Jul; 31(7):1272-8. PubMed ID: 20061362
[TBL] [Abstract][Full Text] [Related]
8. Chemopreventive properties of a selective inducible nitric oxide synthase inhibitor in colon carcinogenesis, administered alone or in combination with celecoxib, a selective cyclooxygenase-2 inhibitor.
Rao CV; Indranie C; Simi B; Manning PT; Connor JR; Reddy BS
Cancer Res; 2002 Jan; 62(1):165-70. PubMed ID: 11782374
[TBL] [Abstract][Full Text] [Related]
9. Modulation of apoptosis by sulindac, curcumin, phenylethyl-3-methylcaffeate, and 6-phenylhexyl isothiocyanate: apoptotic index as a biomarker in colon cancer chemoprevention and promotion.
Samaha HS; Kelloff GJ; Steele V; Rao CV; Reddy BS
Cancer Res; 1997 Apr; 57(7):1301-5. PubMed ID: 9102217
[TBL] [Abstract][Full Text] [Related]
10. Chemopreventive efficacy of sulindac sulfone against colon cancer depends on time of administration during carcinogenic process.
Reddy BS; Kawamori T; Lubet RA; Steele VE; Kelloff GJ; Rao CV
Cancer Res; 1999 Jul; 59(14):3387-91. PubMed ID: 10416599
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of azoxymethane-induced colorectal cancer by CP-31398, a TP53 modulator, alone or in combination with low doses of celecoxib in male F344 rats.
Rao CV; Steele VE; Swamy MV; Patlolla JM; Guruswamy S; Kopelovich L
Cancer Res; 2009 Oct; 69(20):8175-82. PubMed ID: 19826045
[TBL] [Abstract][Full Text] [Related]
12. Chemopreventive efficacy of naproxen and nitric oxide-naproxen in rodent models of colon, urinary bladder, and mammary cancers.
Steele VE; Rao CV; Zhang Y; Patlolla J; Boring D; Kopelovich L; Juliana MM; Grubbs CJ; Lubet RA
Cancer Prev Res (Phila); 2009 Nov; 2(11):951-6. PubMed ID: 19892664
[TBL] [Abstract][Full Text] [Related]
13. Chemoprevention of colon carcinogenesis by concurrent administration of piroxicam, a nonsteroidal antiinflammatory drug with D,L-alpha-difluoromethylornithine, an ornithine decarboxylase inhibitor, in diet.
Reddy BS; Nayini J; Tokumo K; Rigotty J; Zang E; Kelloff G
Cancer Res; 1990 May; 50(9):2562-8. PubMed ID: 2109653
[TBL] [Abstract][Full Text] [Related]
14. Intermittent Dosing Regimens of Aspirin and Naproxen Inhibit Azoxymethane-Induced Colon Adenoma Progression to Adenocarcinoma and Invasive Carcinoma.
Mohammed A; Janakiram NB; Madka V; Zhang Y; Singh A; Biddick L; Li Q; Lightfoot S; Steele VE; Lubet RA; Suen CS; Miller MS; Sei S; Rao CV
Cancer Prev Res (Phila); 2019 Nov; 12(11):751-762. PubMed ID: 31530543
[TBL] [Abstract][Full Text] [Related]
15. Sulindac sulfone inhibits azoxymethane-induced colon carcinogenesis in rats without reducing prostaglandin levels.
Piazza GA; Alberts DS; Hixson LJ; Paranka NS; Li H; Finn T; Bogert C; Guillen JM; Brendel K; Gross PH; Sperl G; Ritchie J; Burt RW; Ellsworth L; Ahnen DJ; Pamukcu R
Cancer Res; 1997 Jul; 57(14):2909-15. PubMed ID: 9230200
[TBL] [Abstract][Full Text] [Related]
16. Chemoprevention of Colon Cancer by DFMO, Sulindac, and NO-Sulindac Administered Individually or in Combinations in F344 Rats.
Madka V; Patlolla JMR; Venkatachalam K; Zhang Y; Pathuri G; Stratton N; Lightfoot S; Janakiram NB; Mohammed A; Rao CV
Cancers (Basel); 2023 Aug; 15(15):. PubMed ID: 37568816
[TBL] [Abstract][Full Text] [Related]
17. The NSAID sulindac is chemopreventive in the mouse distal colon but carcinogenic in the proximal colon.
Mladenova D; Daniel JJ; Dahlstrom JE; Bean E; Gupta R; Pickford R; Currey N; Musgrove EA; Kohonen-Corish MR
Gut; 2011 Mar; 60(3):350-60. PubMed ID: 20980345
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of cyclooxygenase-2 inhibitor for potential chemopreventive properties in colon carcinogenesis.
Reddy BS; Rao CV; Seibert K
Cancer Res; 1996 Oct; 56(20):4566-9. PubMed ID: 8840961
[TBL] [Abstract][Full Text] [Related]
19. Induction of apoptosis by sulindac in azoxymethane-induced possible colonic premalignant lesions in rats.
Kuno T; Yamada Y; Hirose Y; Katayama M; Sakata K; Hara A; Saji S; Mori H
Jpn J Cancer Res; 2002 Mar; 93(3):242-6. PubMed ID: 11927004
[TBL] [Abstract][Full Text] [Related]
20. Preventive potential of wheat bran fractions against experimental colon carcinogenesis: implications for human colon cancer prevention.
Reddy BS; Hirose Y; Cohen LA; Simi B; Cooma I; Rao CV
Cancer Res; 2000 Sep; 60(17):4792-7. PubMed ID: 10987288
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
